life science investing Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
life science investing Interim Data from Accent Pancreatic Cancer Trial Supports Continuation of Trial
pharmaceutical investing Tumour Response in Sixth Patient Triggers Additional Recruitment in Pancreatic Cancer Trial
Nuvau Announces Voting Results of Its Annual and Special Meeting of Shareholders and Announces the Appointment of Steven Bowles as Chair of the Board
SAGA Metals Appoints Accomplished Mining Executive Peter Hogendoorn to Board of Advisors and Engages Xander Capital Partners
Blue Lagoon Announces Major Steps Toward Production: Fully Funded, Government Inspections Passed, and Water Treatment Plant Completed
